2014
DOI: 10.1016/j.canlet.2013.08.030
|View full text |Cite
|
Sign up to set email alerts
|

MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

2
148
0
1

Year Published

2014
2014
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 165 publications
(151 citation statements)
references
References 34 publications
2
148
0
1
Order By: Relevance
“…cell lung cancer (NSCLC), hsa-let-7c inhibits tumor metastasis and invasion via targeting the transcripts encoding integrin 3 and mitogen-activated protein kinase 3 (28). Previous studies have demonstrated that let-7 family members are involved in many carcinogenic pathways, including the Notch signaling pathway, which is associated with a number of diseases in humans (29,30).…”
Section: Discussionmentioning
confidence: 99%
“…cell lung cancer (NSCLC), hsa-let-7c inhibits tumor metastasis and invasion via targeting the transcripts encoding integrin 3 and mitogen-activated protein kinase 3 (28). Previous studies have demonstrated that let-7 family members are involved in many carcinogenic pathways, including the Notch signaling pathway, which is associated with a number of diseases in humans (29,30).…”
Section: Discussionmentioning
confidence: 99%
“…A variety of studies have identified certain miRNAs that suppress the metastasis in lung cancer [9,10,21]. Let-7 is one of the earliest identified miRNAs with significantly reduced expression in a large number of malignant tumors and is known to attenuate the development of lung cancer [22,23]. As for miR-10b and miR-155, the upregulated expression level was significantly positively correlated with TNM stage, lymph node involvement, and poor survival [11,12].…”
Section: Discussionmentioning
confidence: 99%
“…10,11 LncRNA-MALAT-1 was up-regulated during the tumourigenesis of lung cancer and demonstrated to be associated with metastasis in NSCLC patients. 12 Fas apoptotic inhibitory molecule 2 (FAIM2) could inhibit Fas-mediated cell death and was found to be overexpressed in SCLC cell lines.…”
mentioning
confidence: 99%